Renal Function Outcomes in De Novo Kidney Transplant Recipients Receiving Everolimus with Reduced-Exposure Calcineurin Inhibitor versus Mycophenolate with Standard-Exposure Calcineurin Inhibitor

Authors :: Peter Bernhardt
Dirk Kuypers
Rainer Oberbauer
Graeme R. Russ
Federico Oppenheimer
Ayan Das Gupta
Oliver Witzke
Claudia Sommerer
Ondrej Viklicky
Valter Duro Garcia
Romina Danguilan
Source :: Transplantation. 102:S363
Publication Year :: 2018
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2018.

Subjects :: Calcineurin
Transplantation
medicine.medical_specialty
Everolimus
business.industry
Urology
medicine
Renal function
business
Mycophenolate
Kidney transplant
medicine.drug

Full Text Access

Tools